HEPATOCYTE GROWTH FACTOR PLAYS A CRITICAL ROLE IN THE REGULATION OF CYTOKINE PRODUCTION AND INDUCTION OF ENDOTHELIAL PROGENITOR CELL MOBILIZATION: A PILOT GENE THERAPY STUDY IN PATIENTS WITH CORONARY HEART DISEASE

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Clinical and Experimental Pharmacology and Physiology

• Publication date

  2009-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1440-1681.2009.05151.xPMID 19215239
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interleukin-8 as an independent predictor of long-term clinical outcome in patients with coronary artery disease.

  2008cited by this paper
• Growth Factor-Induced Mobilization of Dendritic Cells in Kidney and Liver of Rhesus Macaques: Implications for Transplantation

  2007cited by this paper
• Recruitment of stem cells by hepatocyte growth factor via intracoronary gene transfection in the postinfarction heart failure

  2007cited by this paper
• Experimental study of bone marrow-derived mesenchymal stem cells combined with hepatocyte growth factor transplantation via noninfarct-relative artery in acute myocardial infarction

  2006cited by this paper
• Induction of collateral artery growth and improvement of post-infarct heart function by hepatocyte growth factor gene transfer

  2006influential reference
• Cardiac Overexpression of Monocyte Chemoattractant Protein-1 in Transgenic Mice Prevents Cardiac Dysfunction and Remodeling After Myocardial Infarction

  2006influential reference
• Mobilization of CD34(+), CD117(+), CXCR4(+), c-met(+) stem cells is correlated with left ventricular ejection fraction and plasma NT-proBNP levels in patients with acute myocardial infarction.

  2006cited by this paper
• [Hepatocyte growth factor and kidney].

  2006cited by this paper
• Angiogenic and antifibrotic actions of hepatocyte growth factor improve cardiac dysfunction in porcine ischemic cardiomyopathy

  2006cited by this paper
• Novel therapeutic strategy to treat brain ischemia : overexpression of hepatocyte growth factor gene reduced ischemic injury without cerebral edema in rat model

  2005cited by this paper
• Gene transfection with human hepatocyte growth factor complementary DNA plasmids attenuates cardiac remodeling after acute myocardial infarction in goat hearts implanted with ventricular assist devices.

  2005cited by this paper
• Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells.

  2005cited by this paper
• Targeted deletion of CC chemokine receptor 2 attenuates left ventricular remodeling after experimental myocardial infarction.

  2004cited by this paper
• Novel Therapeutic Strategy to Treat Brain Ischemia: Overexpression of Hepatocyte Growth Factor Gene Reduced Ischemic Injury Without Cerebral Edema in Rat Model

  2004cited by this paper
• Mobilization of CD34/CXCR4+, CD34/CD117+, c-met+ Stem Cells, and Mononuclear Cells Expressing Early Cardiac, Muscle, and Endothelial Markers Into Peripheral Blood in Patients With Acute Myocardial Infarction

  2004cited by this paper
• Of mice and dogs: species-specific differences in the inflammatory response following myocardial infarction.

  2004cited by this paper
• Safety Evaluation of Clinical Gene Therapy Using Hepatocyte Growth Factor to Treat Peripheral Arterial Disease

  2004cited by this paper
• Treatment of acute myocardial infarction by hepatocyte growth factor gene transfer: the first demonstration of myocardial transfer of a "functional" gene using ultrasonic microbubble destruction.

  2004influential reference
• Hepatocyte growth factor induces angiogenesis in injured lungs through mobilizing endothelial progenitor cells.

  2004cited by this paper
• Stem cell repair of infarcted myocardium: an overview for clinicians.

  2003cited by this paper
• Treatment of myocardial ischemia with bone marrow-derived mesenchymal stem cells overexpressing hepatocyte growth factor.

  2003cited by this paper
• Postinfarction Treatment With an Adenoviral Vector Expressing Hepatocyte Growth Factor Relieves Chronic Left Ventricular Remodeling and Dysfunction in Mice

  2003influential reference
• HGF receptor up-regulation contributes to the angiogenic phenotype of human endothelial cells and promotes angiogenesis in vitro.

  2003cited by this paper
• Peripheral Blood “Endothelial Progenitor Cells” Are Derived From Monocyte/Macrophages and Secrete Angiogenic Growth Factors

  2003cited by this paper
• Endothelial progenitor cells: mobilization, differentiation, and homing.

  2003cited by this paper
• Endothelial progenitor cells: new hope for a broken heart.

  2003cited by this paper
• Myocardial Regeneration Therapy for Heart Failure: Hepatocyte Growth Factor Enhances the Effect of Cellular Cardiomyoplasty

  2002cited by this paper
• Chemokine expression in myocardial ischemia: MIP-2 dependent MCP-1 expression protects cardiomyocytes from cell death.

  2002cited by this paper
• Anti-Monocyte Chemoattractant Protein-1 Gene Therapy Attenuates Left Ventricular Remodeling and Failure After Experimental Myocardial Infarction

  2002cited by this paper
• Myocardial regeneration therapy for heart failure: hepatocyte growth factor enhances the effect of cellular cardiomyoplasty.

  2002cited by this paper
• Hepatocyte growth factor: renotropic role and potential therapeutics for renal diseases.

  2001cited by this paper
• Serum Levels of the Antiinflammatory Cytokine Interleukin-10 Are Decreased in Patients With Unstable Angina

  2001cited by this paper
• Effects of interleukin-10 on monocyte/endothelial cell adhesion and MMP-9/TIMP-1 secretion.

  2001cited by this paper
• Monocytes coexpress endothelial and macrophagocytic lineage markers and form cord-like structures in Matrigel under angiogenic conditions.

  2001cited by this paper
• CD34− Blood‐Derived Human Endothelial Cell Progenitors

  2001cited by this paper
• Therapeutic Angiogenesis Induced by Human Hepatocyte Growth Factor Gene in Rat Diabetic Hind Limb Ischemia Model: Molecular Mechanisms of Delayed Angiogenesis in Diabetes

  2001cited by this paper
• Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease

  2001cited by this paper
• Mobilization of Endothelial Progenitor Cells in Patients With Acute Myocardial Infarction

  2001cited by this paper
• Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF.

  2000cited by this paper
• Therapeutic angiogenesis induced by hepatocyte growth factor: potential gene therapy for ischemic diseases.

  2000cited by this paper
• Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization.

  2000cited by this paper
• Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infarcted myocardium: up-regulation of essential transcription factor for angiogenesis, ets

  2000cited by this paper
• Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression.

  2000cited by this paper
• Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization.

  1999cited by this paper
• MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions

  1999cited by this paper
• Hepatocyte growth factor gene therapy of liver cirrhosis in rats

  1999cited by this paper
• Protective role of interleukin-10 in atherosclerosis.

  1999cited by this paper
• Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as cytokine supplement therapy.

  1999cited by this paper
• Hepatocyte growth factor increases expression of vascular endothelial growth factor and plasminogen activator inhibitor-1 in human keratinocytes and the vascular endothelial growth factor receptor flk-1 in human endothelial cells.

  1999cited by this paper
• Hepatocyte growth factor and the kidney: it is not just for the liver.

  1999cited by this paper
• Hepatocyte growth factor prevents renal fibrosis and dysfunction in a mouse model of chronic renal disease.

  1998cited by this paper
• Hepatocyte growth factor/scatter factor (HGF/SF) induces vascular permeability factor (VPF/VEGF) expression by cultured keratinocytes.

  1998cited by this paper
• Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis.

  1998cited by this paper
• A novel vascular modulator, hepatocyte growth factor (HGF), as a potential index of the severity of hypertension.

  1998cited by this paper
• Isolation of Putative Progenitor Endothelial Cells for Angiogenesis

  1997cited by this paper
• Simultaneous or delayed administration of hepatocyte growth factor equally represses the fibrotic changes in murine lung injury induced by bleomycin. A morphologic study.

  1997cited by this paper
• Enhanced expression of hepatocyte growth factor/c-Met by myocardial ischemia and reperfusion in a rat model.

  1997cited by this paper
• Immunocomplexes stimulate different signalling events to chemoattractants in the neutrophil and regulate L-selectin and beta 2-integrin expression differently.

  1994cited by this paper
• Interleukin-8. A mitogen and chemoattractant for vascular smooth muscle cells.

  1994cited by this paper
• Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth

  1992cited by this paper
• Expression of monocyte chemotactic protein and interleukin-8 by cytokine-activated human vascular smooth muscle cells.

  1991cited by this paper
• Secretion of novel and homologous neutrophil-activating peptides by LPS-stimulated human endothelial cells.

  1989cited by this paper
• Molecular cloning and expression of human hepatocyte growth factor

  1989cited by this paper
• A novel neutrophil-activating factor produced by human mononuclear phagocytes

  1988cited by this paper
• A more meaningful scoring system for determining the severity of coronary heart disease.

  1983cited by this paper

• Causal effects of primary aldosteronism on inflammation and bone density: evidence from Mendelian randomization, animal, and clinical studies

  2025cites this paper
• Mechanisms of Postischemic Stroke Angiogenesis: A Multifaceted Approach

  2024cites this paper
• Therapeutic angiogenesis and tissue revascularization in ischemic vascular disease

  2023influential citation
• Nanoparticles and cytokine response

  2023cites this paper
• Amnion bilayer for dressing and graft replacement for delayed grafting of full-thickness burns; A study in a rat model

  2022cites this paper
• Hepatocyte growth factor is upregulated in ischemic retina and contributes to retinal vascular leakage and neovascularization

  2020cites this paper
• Title Hepatocyte growth factor and carotid intima-media thickness in relation tocirculating CD 34-positive cell levels

  2019cites this paper
• RP105 alleviates myocardial ischemia reperfusion injury via inhibiting TLR4/TRIF signaling pathways

  2018cites this paper
• Hepatocyte growth factor and carotid intima-media thickness in relation to circulating CD34-positive cell levels

  2018cites this paper
• Hepatocyte Growth Factor Gene Therapy for Ischemic Diseases

  2018cites this paper
• Interleukin-7 and Immunosenescence

  2017cites this paper
• Safety and Efficacy of Intracoronary Ad-HGF Administration for Treating Severe Coronary Disease: Results From Long-Term Follow-Up of a Phase I Clinical Trial

  2017influential citation
• Ultrasound-targeted microbubble destruction in gene therapy: A new tool to cure human diseases

  2016cites this paper
• Cellular and molecular mechanisms of HGF/Met in the cardiovascular system.

  2015cites this paper
• HGF expression induced by HIF‐1α promote the proliferation and tube formation of endothelial progenitor cells

  2015cites this paper
• Hepatocyte growth factor (HGF) promotes cardiac stem cell differentiation after myocardial infarction by increasing mTOR activation in p27kip haploinsufficient mice

  2015influential citation
• Ex vivo paracrine properties of cardiac tissue: Effects of chronic heart failure.

  2015cites this paper
• HGF/Met Axis in Heart Function and Cardioprotection

  2014cites this paper
• Trophokines: Novel Therapy for Senescence-Related Fibrosis

  2014cites this paper
• Inflammation, advancing age and nutrition

  2014cites this paper
• Therapeutic angiogenesis: recent and future prospects of gene therapy in peripheral artery disease.

  2014cites this paper
• Hepatocyte Growth Factor: Cardiotrophic Roles and Potential Therapeutics for Cardiovascular Diseases

  2014cites this paper
• Hemodialysis‐induced changes in the blood composition affect function of the endothelium

  2014cites this paper
• Refractory angina pectoris: lessons from the past and current perspectives.

  2013cites this paper
• Renoprotective effects of hepatocyte growth factor in the stenotic kidney.

  2013cites this paper
• Hepatocyte growth factor as a long‑term predictor for total and cardiovascular mortality in patients on peritoneal dialysis.

  2013cites this paper
• Potential Target Molecules in Diabetic Cardiomyopathy: Hepatocyte Growth Factor (HGF) and Ryanodine Receptor 2 (RyR2)

  2013cites this paper
• Cardiovascular Gene Therapy

  2013cites this paper
• Papel de las células madre de la médula ósea en hepatología: estudios in vivo e in vitro

  2013cites this paper
• Novel therapy for idiopathic pulmonary arterial hypertension: Can hepatocyte growth factor be beneficial?

  2012cites this paper
• Proof Delivery Form

  2012cites this paper
• Novel Approaches to Deliver Molecular Therapeutics in Cardiac Disease Using Adeno-Associated Virus Vectors

  2012cites this paper
• Prognostic Significance of Circulating Levels of Hepatocyte Growth Factor in Patients with Chagas’ Disease and Idiopathic Dilated Cardiomyopathy

  2012cites this paper
• Novel therapy for myocardial infarction: can HGF/Met be beneficial?

  2011cites this paper
• Gene therapy for ischemic heart disease: review of clinical trials.

  2011cites this paper
• Differential Bone Marrow Hematopoietic Stem Cells Mobilization in Hepatectomized Patients

  2011cites this paper
• Cardiovascular magnetic resonance imaging in delivering and evaluating the efficacy of hepatocyte growth factor gene in chronic infarct scar.

  2011influential citation
• Terapia gênica para cardiopatia isquêmica: revisão de ensaios clínicos Gene therapy for ischemic heart disease: review of clinical trials

  2011cites this paper
• Novel therapy for myocardial infarction: can HGF/Met be beneficial?

  2011cites this paper
• Endothelial progenitor cells: novel biomarker and promising cell therapy for cardiovascular disease.

  2011cites this paper
• Targeting Adenoviral Gene Therapy Vectors to Head and Neck Squamous Cell Carcinoma and Heart

  2010cites this paper
• Skeletal myoblasts for heart regeneration and repair: state of the art and perspectives on the mechanisms for functional cardiac benefits.

  2010cites this paper
• Progenitor Cells for the Treatment of Acute Myocardial Infarction.

  2010cites this paper
• Circulating stem cell populations in preterm infants: implications for the development of retinopathy of prematurity.

  2010cites this paper
• New therapies for the failing heart: trans-genes versus trans-cells.

  2010cites this paper
• Hepatocyte Growth Factor (HGF)-Konzentrationen im Patientenserum sind nach partieller Hepatektomie mit dem Ausmaß an Parenchymverlust und mit postoperativ peripher mobilisierten CD34+ und CD133+ Stammzellen positiv korreliert

  2010cites this paper
• An update on gene therapy in China.

  2009cites this paper
• isquêmica : revisão de ensaios clínicos Gene therapy for ischemic heart disease : review of clinical trials

  year unknowncites this paper